Literature DB >> 20573823

Temporal and spatial resolution of type I and III interferon responses in vivo.

Julia Elisabeth Pulverer1, Ulfert Rand, Stefan Lienenklaus, Daniela Kugel, Natalia Zietara, Georg Kochs, Ronald Naumann, Siegfried Weiss, Peter Staeheli, Hansjörg Hauser, Mario Köster.   

Abstract

Although the action of interferons (IFNs) has been extensively studied in vitro, limited information is available on the spatial and temporal activation pattern of IFN-induced genes in vivo. We created BAC transgenic mice expressing firefly luciferase under transcriptional control of the Mx2 gene promoter. Expression of the reporter with regard to onset and kinetics of induction parallels that of Mx2 and is thus a hallmark for the host response. Substantial constitutive expression of the reporter gene was observed in the liver and most other tissues of transgenic mice, whereas this expression was strongly reduced in animals lacking functional type I IFN receptors. As expected, the reporter gene was induced not only in response to type I (alpha and beta) and type III (lambda) IFNs but also in response to a variety of IFN inducers such as double-stranded RNA, lipopolysaccharide (LPS), and viruses. In vivo IFN subtypes show clear differences with respect to their kinetics of action and to their spatial activation pattern: while the type I IFN response was strong in liver, spleen, and kidney, type III IFN reactivity was most prominent in organs with mucosal surfaces. Infection of reporter mice with virus strains that differ in their pathogenicity shows that the IFN response is significantly altered in the strength of IFN action at sites which are not primarily infected as well as by the onset and duration of gene induction.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20573823      PMCID: PMC2919002          DOI: 10.1128/JVI.00303-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

Review 1.  The Mx GTPase family of interferon-induced antiviral proteins.

Authors:  Otto Haller; Silke Stertz; Georg Kochs
Journal:  Microbes Infect       Date:  2007-09-14       Impact factor: 2.700

Review 2.  The receptor of the type I interferon family.

Authors:  G Uzé; G Schreiber; J Piehler; S Pellegrini
Journal:  Curr Top Microbiol Immunol       Date:  2007       Impact factor: 4.291

Review 3.  Toll-like receptors, RIG-I-like RNA helicases and the antiviral innate immune response.

Authors:  Alex J V Thompson; Stephen A Locarnini
Journal:  Immunol Cell Biol       Date:  2007-07-31       Impact factor: 5.126

Review 4.  Liver: An organ with predominant innate immunity.

Authors:  Bin Gao; Won-Il Jeong; Zhigang Tian
Journal:  Hepatology       Date:  2008-02       Impact factor: 17.425

5.  Differential receptor subunit affinities of type I interferons govern differential signal activation.

Authors:  Eva Jaks; Martynas Gavutis; Gilles Uzé; Jacques Martal; Jacob Piehler
Journal:  J Mol Biol       Date:  2006-11-18       Impact factor: 5.469

6.  Bacterial artificial chromosome transgenesis through pronuclear injection of fertilized mouse oocytes.

Authors:  Kristina Vintersten; Giuseppe Testa; Ronald Naumann; Konstantinos Anastassiadis; A Francis Stewart
Journal:  Methods Mol Biol       Date:  2008

7.  Interleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytes.

Authors:  Sean E Doyle; Heidi Schreckhise; Kien Khuu-Duong; Katherine Henderson; Robert Rosler; Harold Storey; Lena Yao; Hong Liu; Fariba Barahmand-pour; Pallavur Sivakumar; Chung Chan; Carl Birks; Don Foster; Christopher H Clegg; Perdita Wietzke-Braun; Sabine Mihm; Kevin M Klucher
Journal:  Hepatology       Date:  2006-10       Impact factor: 17.425

8.  Alveolar macrophages are the primary interferon-alpha producer in pulmonary infection with RNA viruses.

Authors:  Yutaro Kumagai; Osamu Takeuchi; Hiroki Kato; Himanshu Kumar; Kosuke Matsui; Eiichi Morii; Katsuyuki Aozasa; Taro Kawai; Shizuo Akira
Journal:  Immunity       Date:  2007-08       Impact factor: 31.745

9.  Replication fitness determines high virulence of influenza A virus in mice carrying functional Mx1 resistance gene.

Authors:  Daniel Grimm; Peter Staeheli; Martin Hufbauer; Iris Koerner; Luis Martínez-Sobrido; Alicia Solórzano; Adolfo García-Sastre; Otto Haller; Georg Kochs
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-10       Impact factor: 11.205

Review 10.  Interferon, Mx, and viral countermeasures.

Authors:  Otto Haller; Georg Kochs; Friedemann Weber
Journal:  Cytokine Growth Factor Rev       Date:  2007-08-01       Impact factor: 7.638

View more
  57 in total

1.  IFN-lambda determines the intestinal epithelial antiviral host defense.

Authors:  Johanna Pott; Tanel Mahlakõiv; Markus Mordstein; Claudia U Duerr; Thomas Michiels; Silvia Stockinger; Peter Staeheli; Mathias W Hornef
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-25       Impact factor: 11.205

Review 2.  Type I IFN-mediated regulation of IL-1 production in inflammatory disorders.

Authors:  Kristina Ludigs; Valeriy Parfenov; Renaud A Du Pasquier; Greta Guarda
Journal:  Cell Mol Life Sci       Date:  2012-04-24       Impact factor: 9.261

3.  Kinetic Differences and Synergistic Antiviral Effects Between Type I and Type III Interferon Signaling Indicate Pathway Independence.

Authors:  Emily A Voigt; John Yin
Journal:  J Interferon Cytokine Res       Date:  2015-05-04       Impact factor: 2.607

4.  Beta interferon regulation of glucose metabolism is PI3K/Akt dependent and important for antiviral activity against coxsackievirus B3.

Authors:  J D Burke; L C Platanias; E N Fish
Journal:  J Virol       Date:  2014-01-08       Impact factor: 5.103

Review 5.  Contribution of type III interferons to antiviral immunity: location, location, location.

Authors:  Sergei V Kotenko; Joan E Durbin
Journal:  J Biol Chem       Date:  2017-03-13       Impact factor: 5.157

Review 6.  Type III IFNs: Beyond antiviral protection.

Authors:  Sergei V Kotenko; Amariliz Rivera; Dane Parker; Joan E Durbin
Journal:  Semin Immunol       Date:  2019-06       Impact factor: 11.130

Review 7.  In Vivo Imaging-Driven Approaches to Study Virus Dissemination and Pathogenesis.

Authors:  Pradeep D Uchil; Kelsey A Haugh; Ruoxi Pi; Walther Mothes
Journal:  Annu Rev Virol       Date:  2019-07-05       Impact factor: 10.431

8.  Crystal structure of Zebrafish interferons I and II reveals conservation of type I interferon structure in vertebrates.

Authors:  Ole Jensen Hamming; Georges Lutfalla; Jean-Pierre Levraud; Rune Hartmann
Journal:  J Virol       Date:  2011-06-08       Impact factor: 5.103

Review 9.  Animal Models for the Study of Nucleic Acid Immunity: Novel Tools and New Perspectives.

Authors:  Isabelle K Vila; Maxence Fretaud; Dimitrios Vlachakis; Nadine Laguette; Christelle Langevin
Journal:  J Mol Biol       Date:  2020-08-26       Impact factor: 5.469

Review 10.  Interferon-λs: special immunomodulatory agents and potential therapeutic targets.

Authors:  Ya-wen Zheng; Hui Li; Jin-pu Yu; Hua Zhao; Shizhen Emily Wang; Xiu-bao Ren
Journal:  J Innate Immun       Date:  2012-11-30       Impact factor: 7.349

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.